Texas 2021 - 87th Regular

Texas House Bill HB2609 Compare Versions

OldNewDifferences
11 87R602 SCL-F
2- By: Parker, Raymond, Oliverson, Guillen, H.B. No. 2609
3- et al.
2+ By: Parker H.B. No. 2609
43
54
65 A BILL TO BE ENTITLED
76 AN ACT
87 relating to advance directives or health care or treatment
98 decisions made by or on behalf of patients.
109 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
1110 SECTION 1. This Act may be cited as the Respecting Texas
1211 Patients' Right to Life Act of 2021.
1312 SECTION 2. The purpose of this Act is to protect the right
1413 of patients and their families to decide whether and under what
1514 circumstances to choose or reject life-sustaining treatment. This
1615 Act amends the applicable provisions of the Advance Directives Act
1716 (Chapter 166, Health and Safety Code) to ensure that, when an
1817 attending physician is unwilling to respect a patient's advance
1918 directive or a patient's or family's decision to choose the
2019 treatment necessary to prevent the patient's death,
2120 life-sustaining medical treatment will be provided until the
2221 patient can be transferred to a health care provider willing to
2322 honor the directive or treatment decision.
2423 SECTION 3. Section 166.045(c), Health and Safety Code, is
2524 amended to read as follows:
2625 (c) If an attending physician refuses to comply with a
2726 directive or treatment decision to provide life-sustaining
2827 treatment to a patient [and does not wish to follow the procedure
2928 established under Section 166.046], life-sustaining treatment
3029 shall be provided to the patient[, but only] until [a reasonable
3130 opportunity has been afforded for the transfer of] the patient is
3231 transferred to another physician or health care facility willing to
3332 comply with the directive or treatment decision to provide
3433 life-sustaining treatment to the patient.
3534 SECTION 4. Sections 166.046(a), (b), (d), (e), (e-1), and
3635 (f), Health and Safety Code, are amended to read as follows:
3736 (a) If an attending physician refuses to honor a patient's
3837 advance directive or a health care or treatment decision made by or
3938 on behalf of a patient, other than a directive or decision to
4039 provide artificial nutrition and hydration to the patient, the
4140 physician's refusal shall be reviewed by an ethics or medical
4241 committee. The attending physician may not be a member of that
4342 committee. The patient shall be given life-sustaining treatment
4443 during the review and until the patient is transferred to another
4544 physician or health care facility willing to comply with the
4645 directive or treatment decision to provide life-sustaining
4746 treatment to the patient.
4847 (b) The patient or the person responsible for the health
4948 care decisions of the individual who has made the decision
5049 regarding the directive or treatment decision:
5150 (1) may be given a written description of the ethics or
5251 medical committee review process and any other policies and
5352 procedures related to this section adopted by the health care
5453 facility;
5554 (2) shall be informed of the committee review process
5655 not less than 48 hours before the meeting called to discuss the
5756 patient's directive, unless the time period is waived by mutual
5857 agreement;
5958 (3) at the time of being so informed, shall be
6059 provided[:
6160 [(A) a copy of the appropriate statement set
6261 forth in Section 166.052; and
6362 [(B)] a copy of the registry list of health care
6463 providers and referral groups that have volunteered their readiness
6564 to consider accepting transfer or to assist in locating a provider
6665 willing to accept transfer that is posted on the website maintained
6766 by the department under Section 166.053; and
6867 (4) is entitled to:
6968 (A) attend the meeting;
7069 (B) receive a written explanation of the
7170 recommendations made [decision reached] during the review process;
7271 (C) receive a copy of the portion of the
7372 patient's medical record related to the treatment received by the
7473 patient in the facility for the lesser of:
7574 (i) the period of the patient's current
7675 admission to the facility; or
7776 (ii) the preceding 30 calendar days; and
7877 (D) receive a copy of all of the patient's
7978 reasonably available diagnostic results and reports related to the
8079 medical record provided under Paragraph (C).
8180 (d) If the attending physician, the patient, or the person
8281 responsible for the health care decisions of the individual does
8382 not agree with the recommendations made [decision reached] during
8483 the review process under Subsection (b), the physician shall make a
8584 reasonable effort to transfer the patient to a physician who is
8685 willing to comply with the directive. If the patient is a patient in
8786 a health care facility, the facility's personnel shall assist the
8887 physician in arranging the patient's transfer to:
8988 (1) another physician;
9089 (2) an alternative care setting within that facility;
9190 or
9291 (3) another facility.
9392 (e) If the patient or the person responsible for the health
9493 care decisions of the patient is requesting life-sustaining
9594 treatment that the attending physician [has decided] and the ethics
9695 or medical committee consider [has affirmed is] medically
9796 inappropriate treatment, the patient shall be given available
9897 life-sustaining treatment pending transfer under Subsection (d).
9998 This subsection does not authorize withholding or withdrawing pain
10099 management medication, medical procedures necessary to provide
101100 comfort, or any other health care provided to alleviate a patient's
102101 pain. Artificially [The patient is responsible for any costs
103102 incurred in transferring the patient to another facility. The
104103 attending physician, any other physician responsible for the care
105104 of the patient, and the health care facility are not obligated to
106105 provide life-sustaining treatment after the 10th day after both the
107106 written decision and the patient's medical record required under
108107 Subsection (b) are provided to the patient or the person
109108 responsible for the health care decisions of the patient unless
110109 ordered to do so under Subsection (g), except that artificially]
111110 administered nutrition and hydration must be provided unless, based
112111 on reasonable medical judgment, providing artificially
113112 administered nutrition and hydration would:
114113 (1) hasten the patient's death;
115114 (2) be medically contraindicated such that the
116115 provision of the treatment seriously exacerbates life-threatening
117116 medical problems not outweighed by the benefit of the provision of
118117 the treatment;
119118 (3) result in substantial irremediable physical pain
120119 not outweighed by the benefit of the provision of the treatment;
121120 (4) be medically ineffective in prolonging life; or
122121 (5) be contrary to the patient's or surrogate's
123122 clearly documented desire not to receive artificially administered
124123 nutrition or hydration.
125124 (e-1) If during a previous admission to a facility a
126125 patient's attending physician and the review process under
127126 Subsection (b) have determined that life-sustaining treatment is
128127 inappropriate, and the patient is readmitted to the same facility
129128 within six months from the date of the recommendations made
130129 [decision reached] during the review process conducted upon the
131130 previous admission, Subsections (b) through (e) need not be
132131 followed if the patient's attending physician and a consulting
133132 physician who is a member of the ethics or medical committee of the
134133 facility document on the patient's readmission that the patient's
135134 condition either has not improved or has deteriorated since the
136135 review process was conducted.
137136 (f) Life-sustaining treatment under this section may not be
138137 entered in the patient's medical record as medically unnecessary
139138 treatment [until the time period provided under Subsection (e) has
140139 expired].
141140 SECTION 5. Section 166.051, Health and Safety Code, is
142141 amended to read as follows:
143142 Sec. 166.051. LEGAL RIGHT OR RESPONSIBILITY NOT AFFECTED.
144143 This subchapter does not impair or supersede any legal right or
145144 responsibility a person may have to effect the withholding or
146145 withdrawal of life-sustaining treatment in a lawful manner,
147146 provided that if an attending physician or health care facility is
148147 unwilling to honor a patient's advance directive or a treatment
149148 decision to provide life-sustaining treatment, life-sustaining
150149 treatment must [is required to] be provided to the patient in
151150 accordance with this chapter[, but only until a reasonable
152151 opportunity has been afforded for transfer of the patient to
153152 another physician or health care facility willing to comply with
154153 the advance directive or treatment decision].
155154 SECTION 6. Section 25.0021(b), Government Code, is amended
156155 to read as follows:
157156 (b) A statutory probate court as that term is defined in
158157 Section 22.007(c), Estates Code, has:
159158 (1) the general jurisdiction of a probate court as
160159 provided by the Estates Code; and
161160 (2) the jurisdiction provided by law for a county
162161 court to hear and determine actions, cases, matters, or proceedings
163162 instituted under:
164163 (A) Section [166.046,] 192.027, 193.007,
165164 552.015, 552.019, 711.004, or 714.003, Health and Safety Code;
166165 (B) Chapter 462, Health and Safety Code; or
167166 (C) Subtitle C or D, Title 7, Health and Safety
168167 Code.
169168 SECTION 7. Sections 166.046(g) and 166.052, Health and
170169 Safety Code, are repealed.
171170 SECTION 8. This Act takes effect immediately if it receives
172171 a vote of two-thirds of all the members elected to each house, as
173172 provided by Section 39, Article III, Texas Constitution. If this
174173 Act does not receive the vote necessary for immediate effect, this
175174 Act takes effect September 1, 2021.